fda approvals in msi-high cancers, priority reviews in gastric cancer and fl, and more
Published 7 years ago • 420 plays • Length 9:04
Download video MP4
Download video MP3
Similar videos
-
6:44
fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
7:19
fda approval in hcc, priority reviews in tnbc and ovarian cancer, snda in itp, and more
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
4:34
endometrial cancer uterus fda approved treatment - dr robert debernardo, md
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
7:39
fda approvals in all, ovarian cancer, priority review in ctcl, and snda submitted in rcc
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
10:49
fda approvals in melanoma and breast cancer, and priority reviews in prostate cancer and more
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
1:27
dr. grothey on fda approval of pembrolizumab in msi-high crc
-
6:58
fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
Clip.africa.com - Privacy-policy